Cancer Family
Benign Nervous System Neoplasm
CI-CAN-00000084Explore in graph →
Non-malignant62 active trials2 evidence items
- NCIt
- C4789
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000084Explore in graph →
Clinical trials
232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00314119 | Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1 | completed | — | 17 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07801560 | CyberKnife Radiotherapy for the Treatment of Schwannomas(Schwannomas) | completed | — | 200 | Hartmann Oncology Radiotherapy Group, FranceOTHER | 1 | Sep 9, 2026 |
| clinicaltrials |
| NCT06506578 | Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)(NausiCAA) | completed | — | 100 | University Hospital, BordeauxOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT03194906 | Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | completed | Phase 2 | 41 | St. Jude Children's Research HospitalOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT02860923 | Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy(CRANIOEXE) | completed | Phase 3 | 42 | University Hospital, BordeauxOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04283669 | Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas(NF110) | completed | Phase 2 | 12 | University of Alabama at BirminghamOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT05005845 | NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) | completed | Phase 2 | 199 | NFlection Therapeutics, Inc.INDUSTRY | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05786144 | Vestibular Schwannoma Organoids | completed | — | 100 | Maastricht Radiation OncologyOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07342686 | Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma | completed | — | 500 | West China HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06322342 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | completed | Phase 2 | 18 | Reveal Pharmaceuticals Inc.INDUSTRY | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07305285 | Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma | completed | N/A | 160 | West China HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT03406208 | Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing | completed | N/A | 228 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT02162732 | Molecular-Guided Therapy for Childhood Cancer | completed | N/A | 186 | Giselle ShollerOTHER | 2 | Nov 3, 2025 | clinicaltrials |
| NCT04057976 | Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas | completed | N/A | 38 | King's College Hospital NHS TrustOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT03231306 | Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas(NF108-BINI) | completed | Phase 2 | 45 | University of Alabama at BirminghamOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT03927183 | Extended Support for Persons With Pituitary Tumours After Surgery | completed | N/A | 86 | Göteborg UniversityOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT02249572 | Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.(V-REX) | completed | N/A | 100 | Haukeland University HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04730583 | Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT03531814 | Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials | completed | N/A | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05438290 | DPCP to Treat Cutaneous Neurofibromas Associated With NF1 | completed | Phase 1 | 17 | Nicholas GulatiOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT04241679 | Auditory Nerve Test System During Vestibular Schwannoma Resection(ANTS) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT01938677 | Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study | completed | N/A | 67 | Karolinska InstitutetOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT03326388 | Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours(INSPECT) | completed | Phase 1 / Phase 2 | 14 | Great Ormond Street Hospital for Children NHS Foundation TrustOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT02842723 | Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma) | completed | Phase 2 | 33 | Institut CurieOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT02839720 | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Dec 6, 2023 | clinicaltrials |
| NCT00019578 | Stereotactic Radiosurgery in Treating Patients With Brain Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04351373 | Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 | completed | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT03581331 | Consequence of Unilateral Vestibular Loss on Visual Abilities(SVorthoptie) | completed | N/A | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03958006 | Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma | completed | N/A | 6 | Henry Ford Health SystemOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT04584086 | Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received(BRAIN TEL) | completed | N/A | 20 | Centre Francois BaclesseOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03542773 | Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET | completed | Phase 1 | 38 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT03666507 | Vegetative Monitoring During Brainstem-associated Surgery | completed | — | 103 | University Hospital TuebingenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT02849743 | Intranasal Oxytocin in Hypothalamic Obesity | completed | Phase 2 | 18 | Shana McCormack, MDOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT04658836 | Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF | completed | Phase 1 | 21 | Medical University of ViennaOTHER | 1 | Aug 24, 2022 | clinicaltrials |
| NCT04435665 | NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) | completed | Phase 2 | 48 | NFlection Therapeutics, Inc.INDUSTRY | 1 | Aug 9, 2022 | clinicaltrials |
| NCT01129687 | Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy | completed | — | 157 | Stanford UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT02948790 | Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma(NeuriStim) | completed | N/A | 17 | Oticon MedicalINDUSTRY | 1 | Oct 20, 2021 | clinicaltrials |
| NCT02934256 | Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors(Icotinib) | completed | Phase 2 | 10 | Li PengOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04351035 | National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry | completed | — | 4,303 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04937335 | Craniopharyngioma With Tumoral Hemorrhage | completed | — | 185 | Tongji HospitalOTHER | 0 | Jun 24, 2021 | clinicaltrials |
| NCT01800032 | PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) | completed | — | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT01125046 | Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas | completed | Phase 2 | 50 | Northwestern UniversityOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00863122 | Concentration and Activity of Lapatinib in Vestibular Schwannomas | completed | Early Phase 1 | 26 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT01024907 | Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas | completed | Phase 1 / Phase 2 | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT01347307 | Stereotactic Body Radiotherapy for Spine Tumors | completed | N/A | 38 | Mercy ResearchOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT00727233 | Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas | completed | Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01272622 | Prospective Study of Children and Adolescents With Craniopharyngioma | completed | N/A | 120 | Klinikum Oldenburg gGmbHOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT03330080 | Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients | completed | — | 41 | St. Jude Children's Research HospitalOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02309099 | Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach | completed | N/A | 10 | University of North Carolina, Chapel HillOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT01207687 | Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2018 | clinicaltrials |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials